TNXP Q3 FY2026 earnings: results, stock reaction and implied move

Reported results

GAAP net product revenue for the third quarter of 2026 was approximately $17.2 million, compared to $3.3 million for the third quarter of 2025.
Net revenue from sales of TONMYA for the third quarter of 2026 was approximately $15.0 million.
GAAP research and development expenses were approximately $25.8 million for the third quarter of 2026, compared to $9.3 million for the third quarter of 2025.
GAAP selling, general, and administrative expenses were approximately $45.6 million for the third quarter of 2026, compared to $25.7 million for the third quarter of 2025.
GAAP net loss available to common stockholders was $53.3 million, or $2.89 per basic and diluted share, for the third quarter of 2026, compared to $32.0 million, or $3.59 per basic and diluted share, for the third quarter of 2025.
Cash and cash equivalents as of September 30, 2026, were approximately $163 million.

The Company believes that its cash resources as of September 30, 2026, together with net proceeds of approximately $1.5 million raised from equity offerings subsequent to September 30, 2026, will meet its operating and capital expenditure requirements into the early third quarter of 2027.

The figures above come from the earnings release the company filed with the SEC on 2026-11-09 (8-K, Item 2.02). Read the original filing on sec.gov.